Dantrolene sodium in athetoid cerebral palsy.
D000203:Activities of Daily Living; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001264:Athetosis / Q000188:drug therapy*; D002547:Cerebral Palsy / Q000188:drug therapy*; D002648:Child; D002986:Clinical Trials as Topic; D003620:Dantrolene / Q000008:administration & dosage / Q000627:therapeutic use; D004361:Drug Tolerance; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006827:Hydantoins / Q000627:therapeutic use*; D008297:Male; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D010919:Placebos; D012964:Sodium / Q000008:administration & dosage / Q000627:therapeutic use
D006827:Hydantoins; D009125:Muscle Relaxants, Central; D010919:Placebos; D012964:Sodium; D003620:Dantrolene